FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DAPTOMYCIN
daptomycin
Growth
MAIA Biotechnology
INTRAVENOUS · POWDER
pneumonialeft-sided infective endocarditis due to S+13
2024
NDA30/100
DAPTOMYCIN
daptomycin
Peak
Hikma
INTRAVENOUS · POWDER
pneumonialeft-sided infective endocarditis due to S+13
2017
NDA30/100
DAPTOMYCIN
daptomycin
Peak
Sagent Pharmaceuticals
INTRAVENOUS · POWDER
pneumonialeft-sided infective endocarditis due to S+13
2017
NDA30/100
DARANIDE
dichlorphenamide
LOE Approaching
ORAL · TABLET
primary hyperkalemic periodic paralysisprimary hypokalemic periodic paralysis+1
1958
NDA30/100
DARAPRIM
pyrimethamine
LOE Approaching
ORAL · TABLET
toxoplasmosissince synergism exists with this combination
1953
NDA30/100
DARBID
isopropamide iodide
LOE Approaching
GSK
ORAL · TABLET
1957
NDA30/100
DARTISLA ODT
glycopyrrolate
Peak
Bridge Therapeutics
ORAL · TABLET, ORALLY DISINTEGRATING
symptoms of a peptic ulcer
2021
NDA30/100
DARVOCET
acetaminophen; propoxyphene hydrochloride
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA30/100
DARVOCET-N 100
acetaminophen; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA30/100
DARVOCET-N 50
acetaminophen; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1972
NDA30/100
DARVON
propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA30/100
DARVON COMPOUND
aspirin; caffeine; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA30/100
DARVON COMPOUND-65
aspirin; caffeine; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA30/100
DARVON W/ ASA
aspirin; propoxyphene hydrochloride
LOE Approaching
ORAL · CAPSULE
1957
NDA30/100
DARVON-N
propoxyphene napsylate
LOE Approaching
ORAL · SUSPENSION
1971
NDA30/100
DARVON-N
propoxyphene napsylate
LOE Approaching
ORAL · TABLET
1971
NDA30/100
DARVON-N W/ ASA
aspirin; propoxyphene napsylate
LOE Approaching
ORAL · CAPSULE
1971
NDA30/100
DARVON-N W/ ASA
aspirin; propoxyphene napsylate
LOE Approaching
ORAL · TABLET
1971
NDA30/100
DATSCAN
ioflupane i-123
LOE Approaching
INTRAVENOUS · SOLUTION
2011
NDA30/100
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
leukemia
1998
NDA30/100
DAUNOXOME
daunorubicin citrate
LOE Approaching
INJECTION · INJECTABLE, LIPOSOMAL
1996
NDA30/100
DAYPRO
oxaprozin
LOE Approaching
Pfizer
ORAL · TABLET
rheumatoid arthritis
1992
NDA30/100
DAYPRO ALTA
oxaprozin potassium
LOE Approaching
Pfizer
ORAL · TABLET
2002
NDA30/100
DAYTRANA
methylphenidate
LOE Approaching
Noven Pharmaceuticals
TRANSDERMAL · FILM, EXTENDED RELEASE
Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age
2006
NDA30/100